Vanguard Group’s Lyra Therapeutics LYRA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $261K | Sell |
29,178
-1,736,407
| -98% | -$15.6M | ﹤0.01% | 4041 |
|
|
2025
Q1 | $222K | Sell |
1,765,585
-21,837
| -1% | -$2.75K | ﹤0.01% | 4051 |
|
|
2024
Q4 | $368K | Buy |
1,787,422
+8,159
| +0.5% | +$1.68K | ﹤0.01% | 4012 |
|
|
2024
Q3 | $457K | Buy |
1,779,263
+48,348
| +3% | +$12.4K | ﹤0.01% | 3992 |
|
|
2024
Q2 | $479K | Buy |
1,730,915
+249,434
| +17% | +$69K | ﹤0.01% | 4023 |
|
|
2024
Q1 | $9.21M | Buy |
1,481,481
+410,021
| +38% | +$2.55M | ﹤0.01% | 3007 |
|
|
2023
Q4 | $5.61M | Buy |
1,071,460
+207,128
| +24% | +$1.09M | ﹤0.01% | 3240 |
|
|
2023
Q3 | $3.38M | Buy |
864,332
+73,396
| +9% | +$287K | ﹤0.01% | 3411 |
|
|
2023
Q2 | $3.25M | Hold |
790,936
| – | – | ﹤0.01% | 3486 |
|
|
2023
Q1 | $1.59M | Hold |
790,936
| – | – | ﹤0.01% | 3758 |
|
|
2022
Q4 | $2.48M | Buy |
790,936
+316
| +0% | +$992 | ﹤0.01% | 3586 |
|
|
2022
Q3 | $3.96M | Buy |
790,620
+114,951
| +17% | +$576K | ﹤0.01% | 3437 |
|
|
2022
Q2 | $3.82M | Buy |
675,669
+456,916
| +209% | +$2.58M | ﹤0.01% | 3517 |
|
|
2022
Q1 | $879K | Hold |
218,753
| – | – | ﹤0.01% | 4250 |
|
|
2021
Q4 | $954K | Sell |
218,753
-1,276
| -0.6% | -$5.57K | ﹤0.01% | 4280 |
|
|
2021
Q3 | $2.01M | Hold |
220,029
| – | – | ﹤0.01% | 4051 |
|
|
2021
Q2 | $1.77M | Buy |
220,029
+8,143
| +4% | +$65.4K | ﹤0.01% | 4003 |
|
|
2021
Q1 | $2.46M | Buy |
211,886
+38,163
| +22% | +$442K | ﹤0.01% | 3819 |
|
|
2020
Q4 | $1.98M | Buy |
173,723
+22,098
| +15% | +$252K | ﹤0.01% | 3661 |
|
|
2020
Q3 | $1.7M | Buy |
151,625
+116,966
| +337% | +$1.31M | ﹤0.01% | 3532 |
|
|
2020
Q2 | $393K | Buy |
+34,659
| New | +$393K | ﹤0.01% | 3821 |
|